Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational

Tong Liu1, Zheng Wu1, Jinghua Liu2

  • 1Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, No. 2 Anzhen Street, Chaoyang District, Beijing, 100029, China.

Insights

Metabolic syndrome (MetS) and its components, particularly body mass index, are linked to poorer coronary collateralization (CC) in patients with chronic total occlusion (CTO). Higher MetS severity correlates with reduced CC, highlighting its role in cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Vascular Biology

Background:

  • Metabolic syndrome (MetS) is a significant independent risk factor for cardiovascular diseases.
  • Chronic total occlusion (CTO) presents challenges in cardiovascular interventions.
  • The relationship between MetS and coronary collateralization (CC) in CTO is not fully understood.

Purpose of the Study:

  • To investigate the association between MetS and its components with CC in patients with CTO.
  • To determine the extent to which MetS influences the development of coronary collateralization.

Main Methods:

  • A study of 1653 inpatients with CTO.
  • Data collection included demographic and clinical characteristics.
  • Coronary collateralization was assessed using the Rentrop scoring system.
  • Statistical analyses included subgroup analysis, mixed model regression, and ROC curve analysis.

Main Results:

  • The incidence of MetS was higher in patients with poor CC compared to those with good CC.
  • Poor collateralization increased progressively with the number of MetS diagnostic criteria met.
  • Body Mass Index (BMI) was consistently identified as a risk factor for CC growth across all patient groups.
  • MetS was confirmed as an independent risk factor for CC growth in several regression models.

Conclusions:

  • Metabolic syndrome, especially elevated BMI, significantly increases the risk of poor coronary collateralization in CTO patients.
  • The findings suggest that MetS negatively impacts the development of collateral circulation in the context of CTO.
  • Further research into scoring systems for MetS in CTO patients is warranted to improve risk stratification and management.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
144
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
581
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
65
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
107
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
115
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89